Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples